206 top medical experts on GM2 Gangliosidoses across 16 countries and 14 U.S. states, including 26 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. GM2 Gangliosidoses: A group of recessively inherited diseases characterized by the intralysosomal accumulation of G(M2) ganglioside in the neuronal cells. Subtypes include mutations of enzymes in the beta-N-acetylhexosaminidases system or G(M2) activator protein leading to disruption of normal degradation of gangliosides, a subclass of acidic glycosphingolipids.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Gangliosidoses (66) and Narrower Categories: AB Variant Tay-Sachs Disease (9), Sandhoff Disease (538), Tay-Sachs Disease (518).
  4. Clinical Trials ClinicalTrials.gov : at least 14 including 1 Active, 4 Completed, 6 Recruiting
  5. Synonyms: G(M2) Gangliosidoses


  

        

                    


    Computing Expert Listing ...

);